Tapentadol IR 50 mg
CR100459
Phase 3 small_molecule completed
Quick answer
Tapentadol IR 50 mg for Hallux Valgus is a Phase 3 program (small_molecule) at Janssen Cilag International NV with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen Cilag International NV
- Indication
- Hallux Valgus
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed